Corbus Pharmaceuticals Holdings, Inc. Shares Outstanding

Quick Answer

Corbus Pharmaceuticals Holdings, Inc. reported Shares Outstanding of 17.61 million shares for fiscal year 2025.

Corbus Pharmaceuticals Holdings, Inc. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 17.61M +44.6%
2024 12.18M +175.3%
2023 4.42M +6.1%
2022 4.17M +0.0%
2021 4.17M -95.8%
2020 98.85M +52.9%
2019 64.67M +13.0%
2018 57.25M +3.0%
2017 55.60M +24.4%
2016 44.68M +18.8%
2015 37.61M +45.0%
2014 25.94M +272.4%
2013 6.96M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 12.53M +2.9% +2.3%
June 30, 2025 12.25M +6.6% +0.2%
March 31, 2025 12.23M +16.4% +0.4%
December 31, 2024 12.18M +175.3% +0.0%
September 30, 2024 12.18M +175.3% +5.9%
June 30, 2024 11.50M +160.0% +9.4%
March 31, 2024 10.51M +149.3% +137.5%
December 31, 2023 4.42M +6.1% +0.0%
  • Corbus Pharmaceuticals Holdings, Inc. showed an increase of +44.6% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2013–2025 period, Corbus Pharmaceuticals Holdings, Inc.’s shares outstanding has grown by 152.9% (from 6.96 million shares to 17.61 million shares).
  • The most recent figure is from Corbus Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment